Coinhibitory pathways in immunotherapy for cancer
SH Baumeister, GJ Freeman, G Dranoff… - Annual review of …, 2016 - annualreviews.org
The immune system is capable of recognizing tumors and eliminates many early malignant
cells. However, tumors evolve to evade immune attack, and the tumor microenvironment is …
cells. However, tumors evolve to evade immune attack, and the tumor microenvironment is …
Coinhibitory Pathways in Immunotherapy for Cancer
SH Baumeister, GJ Freeman, G Dranoff… - Annual Review of …, 2016 - cir.nii.ac.jp
抄録< jats: p> The immune system is capable of recognizing tumors and eliminates many
early malignant cells. However, tumors evolve to evade immune attack, and the tumor …
early malignant cells. However, tumors evolve to evade immune attack, and the tumor …
Coinhibitory Pathways in Immunotherapy for Cancer.
SH Baumeister, GJ Freeman, G Dranoff… - Annual Review of …, 2016 - europepmc.org
The immune system is capable of recognizing tumors and eliminates many early malignant
cells. However, tumors evolve to evade immune attack, and the tumor microenvironment is …
cells. However, tumors evolve to evade immune attack, and the tumor microenvironment is …
Coinhibitory Pathways in Immunotherapy for Cancer
SH Baumeister, GJ Freeman… - Annual review of …, 2016 - pubmed.ncbi.nlm.nih.gov
The immune system is capable of recognizing tumors and eliminates many early malignant
cells. However, tumors evolve to evade immune attack, and the tumor microenvironment is …
cells. However, tumors evolve to evade immune attack, and the tumor microenvironment is …